Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Mirabegron”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Early research (Phase 1)Study completedNCT00856570
What this trial is testing

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

Who this might be right for
Overactive BladderPharmacokinetics
Astellas Pharma Inc 24
Post-approval studies (Phase 4)Study completedNCT01964183
What this trial is testing

Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

Who this might be right for
Pharmacokinetics of Mirabegron and TolterodineHealthy
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT01747564
What this trial is testing

Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

Who this might be right for
Healthy SubjectsPlasma Concentration of Mirabegron
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT02010944
What this trial is testing

Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Who this might be right for
Phase 1BioavailabilityHealthy Subjects
Astellas Pharma Europe B.V. 72
Post-approval studies (Phase 4)Study completedNCT04501640
What this trial is testing

Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Who this might be right for
Pharmacokinetics of MirabegronFood EffectHealthy Chinese Subjects
Astellas Pharma China, Inc. 24
Early research (Phase 1)Study completedNCT00965926
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers

Who this might be right for
Healthy VolunteerPharmacokinetics of YM178
Astellas Pharma Inc 72
Early research (Phase 1)Study completedNCT01297179
What this trial is testing

Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill

Who this might be right for
Healthy VolunteersPharmacokinetics of Mirabegron
Astellas Pharma Inc 30
Early research (Phase 1)Study completedNCT01478568
What this trial is testing

To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together

Who this might be right for
Pharmacokinetics of MirabegronHealthy Subjects
Astellas Pharma Inc 28
Early research (Phase 1)Study completedNCT01334905
What this trial is testing

Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers

Who this might be right for
Healthy VolunteerPharmacokinetics of YM178
Astellas Pharma Inc 12
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Early research (Phase 1)Study completedNCT01478490
What this trial is testing

To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol

Who this might be right for
Pharmacokinetics of MirabegronHealthy Subjects
Astellas Pharma Inc 28
Early research (Phase 1)Study completedNCT01720212
What this trial is testing

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Astellas Pharma China, Inc. 24
Early research (Phase 1)Study completedNCT01646294
What this trial is testing

Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

Who this might be right for
Pharmacokinetics of YM178Healthy Subjects
Astellas Pharma Europe B.V. 34
Early research (Phase 1)Study completedNCT01663961
What this trial is testing

Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

Who this might be right for
Healthy
Astellas Pharma Europe B.V. 25
Large-scale testing (Phase 3)Ended earlyNCT04641975
What this trial is testing

Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)

Who this might be right for
Overactive Bladder (OAB)Pharmacokinetics of Mirabegron
Astellas Pharma Global Development, Inc. 26
Early research (Phase 1)Study completedNCT02169713
What this trial is testing

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
Astellas Pharma Europe B.V. 20
Early research (Phase 1)Study completedNCT01478529
What this trial is testing

Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

Who this might be right for
Pharmacokinetics of MirabegronBioavailabilityHealthy Subjects
Astellas Pharma Inc 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Early research (Phase 1)Study completedNCT02211846
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Who this might be right for
Neurogenic Detrusor OveractivityOveractive BladderPharmacokinetics of Mirabegron
Astellas Pharma Inc 34
Early research (Phase 1)Study completedNCT00776516
What this trial is testing

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

Who this might be right for
Pharmacokinetics of YM178
Astellas Pharma Inc 24
Next Page